Chow LQM (2020) Head and Neck Cancer. N Engl J Med 382(1):60–72

Article  CAS  PubMed  Google Scholar 

Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24(14):2137–2150

Article  PubMed  Google Scholar 

Gaipl US, Multhoff G, Scheithauer H, Lauber K, Hehlgans S, Frey B, Rödel F (2014) Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy. Immunotherapy 6(5):597–610

Article  CAS  PubMed  Google Scholar 

Qian JM, Schoenfeld JD (2020) Radiotherapy and immunotherapy for head and neck cancer: current evidence and challenges. Front Oncol 10:608772

Article  PubMed  Google Scholar 

Lee NY, Ferris RL, Psyrri A, Haddad RI, Tahara M, Bourhis J et al (2021) Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. Lancet Oncol 22(4):450–462

Article  CAS  PubMed  Google Scholar 

Tao Y, Auperin A, Sun X, Sire C, Martin L, Coutte A et al (2020) Avelumab-cetuximab-radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial GORTEC 2017–01 (REACH). Eur J Cancer 141:21–29

Article  CAS  PubMed  Google Scholar 

Tao Y, Biau J, Sun XS, Sire C, Martin L, Alfonsi M et al (2023) Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015–01 PembroRad): a multicenter, randomized, phase II trial. Ann Oncol 34(1):101–110

Article  CAS  PubMed  Google Scholar 

Machiels JP, Tao Y, Burtness B, Tahara M, Licitra L, Rischin D et al (2020) Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412. Future Oncol 16(18):1235–1243

Article  CAS  PubMed  Google Scholar 

Darragh LB, Gadwa J, Pham TT, Van Court B, Neupert B, Olimpo NA et al (2022) Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors. Nat Commun 13(1):7015

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saddawi-Konefka R, O’Farrell A, Faraji F, Clubb L, Allevato MM, Jensen SM et al (2022) Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC. Nat Commun 13(1):4298

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morisada M, Clavijo PE, Moore E, Sun L, Chamberlin M, Van Waes C et al (2018) PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation. Oncoimmunology 7(3):e1395996

Article  PubMed  Google Scholar 

Oweida A, Lennon S, Calame D, Korpela S, Bhatia S, Sharma J et al (2017) Ionizing radiation sensitizes tumors to PD-L1 immune checkpoint blockade in orthotopic murine head and neck squamous cell carcinoma. Oncoimmunology 6(10):e1356153

Article  PubMed  PubMed Central  Google Scholar 

Oweida A, Hararah MK, Phan A, Binder D, Bhatia S, Lennon S et al (2018) Resistance to radiotherapy and PD-L1 blockade is mediated by TIM-3 upregulation and regulatory T-cell infiltration. Clin Cancer Res 24(21):5368–5380

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim SS, Shen S, Miyauchi S, Sanders PD, Franiak-Pietryga I, Mell L et al (2020) B cells improve overall survival in HPV-associated squamous cell carcinomas and are activated by radiation and PD-1 blockade. Clin Cancer Res 26(13):3345–3359

Article  CAS  PubMed  PubMed Central  Google Scholar 

Newton JM, Hanoteau A, Liu HC, Gaspero A, Parikh F, Gartrell-Corrado RD et al (2019) Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition. J Immunother Cancer 7(1):216

Article  PubMed  PubMed Central  Google Scholar 

Hanoteau A, Newton JM, Krupar R, Huang C, Liu HC, Gaspero A et al (2019) Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy. J Immunother Cancer 7(1):10

Article  PubMed  PubMed Central  Google Scholar 

Xiao R, Allen CT, Tran L, Patel P, Park SJ, Chen Z et al (2018) Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer. Oncoimmunology 7(9):e1471440

Article  PubMed  PubMed Central  Google Scholar 

Patin EC, Dillon MT, Nenclares P, Grove L, Soliman H, Leslie I et al (2022) Harnessing radiotherapy-induced NK-cell activity by combining DNA damage-response inhibition and immune checkpoint blockade. J Immunother Cancer 10(3):e004306

Ansems M, Span PN (2020) The tumor microenvironment and radiotherapy response; a central role for cancer-associated fibroblasts. Clin Transl Radiat Oncol 22:90–97

PubMed  PubMed Central  Google Scholar 

de Visser KE, Joyce JA (2023) The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell 41(3):374–403

Article  PubMed  Google Scholar 

Xu BL, Wang XM, Chen GY, Yuan P, Han L, Qin P et al (2022) In vivo growth of subclones derived from lewis lung carcinoma is determined by the tumor microenvironment. Am J Cancer Res 12(11):5255–5270

PubMed  PubMed Central  Google Scholar 

Yoo SH, Keam B, Ock CY, Kim S, Han B, Kim JW et al (2019) Prognostic value of the association between MHC class I downregulation and PD-L1 upregulation in head and neck squamous cell carcinoma patients. Sci Rep 9(1):7680

Article  PubMed  PubMed Central  Google Scholar 

Sanchez-Canteli M, Granda-Diaz R, Del Rio-Ibisate N, Allonca E, Lopez-Alvarez F, Agorreta J et al (2020) PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas. Cancer Immunol Immunother 69(10):2089–2100

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou Z, Mu D, Zhang D, Zhang X, Ding X, Yang J et al (2020) PD-L1 in combination with CD8+ TIL and HIF-1α are promising prognosis predictors of head and neck squamous cell carcinoma. Cancer Manag Res 12:13233–13239

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wuerdemann N, Gültekin SE, Pütz K, Wittekindt C, Huebbers CU, Sharma SJ et al (2020) PD-L1 expression and a high tumor infiltrate of CD8+ lymphocytes predict outcome in patients with oropharyngeal squamous cells carcinoma. Int J Mol Sci 21(15):5228

Article  CAS  PubMed  PubMed Central  Google Scholar 

Williams JB, Li S, Higgs EF, Cabanov A, Wang X, Huang H, Gajewski TF (2020) Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-gamma-signaling mutant cancer cells. Nat Commun 11(1):602

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao J, Shi LZ, Zhao H, Chen J, Xiong L, He Q et al (2016) Loss of IFN-γ pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy. Cell 167(2):397-404 e9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kono M, Saito S, Egloff AM, Allen CT, Uppaluri R (2022) The mouse oral carcinoma (MOC) model: A 10-year retrospective on model development and head and neck cancer investigations. Oral Oncol 132:106012

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morisada M, Moore EC, Hodge R, Friedman J, Cash HA, Hodge JW et al (2017) Dose-dependent enhancement of T-lymphocyte priming and CTL lysis following ionizing radiation in an engineered model of oral cancer. Oral Oncol 71:87–94

Article  PubMed  PubMed Central